(Q37701881)

English

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience

scientific article published on 02 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

0 references

1 reference

based on heuristic

inferred from title

11

object named as

Keith T Flaherty

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Jedd D. Wolchok

18

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

19

object named as

F Stephen Hodi

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Anita Giobbie-Hurder

7

object named as

Anita Giobbie-Hurder

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sandra P D'Angelo

14

object named as

Sandra D'Angelo

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Nageatte Ibrahim

9

object named as

Nageatte Ibrahim

1 reference

Europe PubMed Central

22 August 2017

PMC publication ID

Michael A Postow

3

object named as

Michael A Postow

1 reference

Europe PubMed Central

22 August 2017

PMC publication ID

5

object named as

Nikhil Ramaiya

1 reference

Europe PubMed Central

22 August 2017

PMC publication ID

author name string

Jason J Luke

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Margaret K Callahan

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Emanuela Romano

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Mark Bluth

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Donald P Lawrence

8

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Patrick A Ott

10

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Ryan J Sullivan

12

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

James J Harding

13

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Mark Dickson

15

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Gary K Schwartz

16

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Paul B Chapman

17

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Richard D Carvajal

20

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

language of work or name

0 references

publication date

2 August 2013

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

119

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

3687-3695

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Incidence of uveal melanoma in the United States: 1973-1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

23 August 2017

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

28 September 2017

Ipilimumab activity in advanced uveal melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

1 September 2018

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

1 September 2018

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

1 September 2018

Variates of survival in metastatic uveal melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

1 September 2018

Very long-term prognosis of patients with malignant uveal melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986037

1 September 2018

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28282

21 January 2018

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.28282

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37701881&oldid=2237097413"